1. Japan Stocks

  2. •

    Technology

  3. •

    Software - Application
Genetec Corporation

Genetec Corporation

4492.T
Genetec CorporationJP flagTokyo Stock Exchange
423.00
JPY
+12.00
- -
4.89BMarket Cap

Total Valuation

Genetec Corporation carries a market capitalization of 4.89B, placing it among publicly traded companies globally. Its enterprise value stands at 6.84B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.89B
Enterprise Value6.84B

Share Statistics

Genetec Corporation currently has 11.44M shares outstanding.

Shares Outstanding11.44M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Genetec Corporation trades at a trailing price-to-earnings ratio of 24.65. The price-to-sales ratio is 1.82, and the price-to-book ratio stands at 4.17.

PE Ratio24.65
PS Ratio1.82
PB Ratio4.17
P/TBV Ratio5.60
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Genetec Corporation trades at an EV/EBITDA multiple of 15.78 and an EV/FCF ratio of 2,954.56. The EV/Sales ratio of 1.71 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.78 provides insight into valuation relative to core operating earnings.

EV / Sales1.71
EV / EBITDA15.78
EV / EBIT15.78
EV / FCF2,954.56

Financial Position

Genetec Corporation maintains a current ratio of 1.74, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 58.10, indicating elevated leverage, while an interest coverage ratio of 127.74 demonstrates strong ability to service its debt obligations.

Current Ratio1.74
Quick Ratio0.88
Debt / Equity58.10
Debt / EBITDA3.02
Interest Coverage127.74

Financial Efficiency

Genetec Corporation posts a return on equity of 18.43 and a return on invested capital of 9.13.

Return on Equity (ROE)18.43
Return on Assets (ROA)6.73
Return on Invested Capital (ROIC)9.13
Return on Capital Employed (ROCE)11.26
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover12.44

Taxes

Over the trailing twelve months, Genetec Corporation has paid 137.29M in income taxes, reflecting an effective tax rate of 31.75.

Income Tax137.29M
Effective Tax Rate31.75

Stock Price Statistics

Genetec Corporation's stock has declined approximately -3.86364% over the past 52 weeks. The 50-day moving average sits at 404.68, while the 200-day moving average is 454.99.

Beta (5Y)N/A
52-Week Price Change-3.86364%
50-Day Moving Average404.68
200-Day Moving Average454.99
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Genetec Corporation generated 3.99B in revenue and converted that into 295.06M in net income, yielding earnings per share of 25.74. EBITDA reached 433.31M, while operating income came in at 433.31M.

Revenue3.99B
Gross Profit1.67B
Operating Income433.31M
Pretax Income432.35M
Net Income295.06M
EBITDA433.31M
EBIT433.31M
Earnings Per Share (EPS)25.74

Balance Sheet

Genetec Corporation holds 1.74B in cash and equivalents against 1.31B in total debt, resulting in a net debt position of -434.53M. Total book value stands at 1.74B, with working capital of 1.46B providing operational flexibility.

Cash & Cash Equivalents1.74B
Total Debt1.31B
Net Debt-434.53M
Equity (Book Value)1.74B
Book Value Per Share153.01
Working Capital1.46B

Margins

Genetec Corporation operates with a gross margin of 41.75, reflecting its pricing power and cost economics. The operating margin of 10.86 and net profit margin of 7.40 provide insight into operational efficiency.

Gross Margin41.75
Operating Margin10.86
Pretax Margin10.84
Profit Margin7.40
EBITDA Margin10.86

Stock Splits

Genetec Corporation's most recent stock split took place on December 28, 2023 with a 1:3 split ratio.

Last Split Date12/28/2023
Split Ratio1:3

Scores

Genetec Corporation posts an Altman Z-Score of 3.95, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.95